Melatonin against acute infections

Recent research suggests melatonin may be an important adjunct to COVID-19 treatment
   
Patients hospitalized with pneumonia and COVID-19 who were given high-dose melatonin as an adjunct therapy to standard of care improved within four to five days, and all survived

Melatonin inhibits the cytokine storm associated with critical SARS-CoV-2 infection. It also inhibits sepsis (blood poisoning), associated with an overactive immune response
   
Melatonin helps prevent mitochondrial impairment, energy failure and apoptosis (programmed cell death) in mitochondria damaged by oxidation

Melatonin also helps regulate and improve risk factors for severe COVID-19, such as high blood pressure, insulin resistance and diabetes

Read the full analysis by Dr. Mercola

 

 

George W. Bush: The terrorists want to change our lifestyle